CLINICAL TRIALS PROFILE FOR XTAMPZA ER
✉ Email this page to a colleague
All Clinical Trials for XTAMPZA ER
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03317730 ↗ | Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer | Completed | University of Alabama at Birmingham | Early Phase 1 | 2018-05-01 | To confirm the feasibility of studying Xtampza ER during radiotherapy (RT) for LAHNC as part of a prospective clinical trial. |
NCT03588806 ↗ | Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid Pills | Terminated | Collegium Pharmaceutical, Inc. | Phase 4 | 2018-05-01 | This study will examine how the use of Xtampza ER, an opioid analgesic packaged in openable microsphere-containing capsules, affects swallowing satisfaction, pain, and physical and mental health outcomes in chronic pain patients. |
NCT03588806 ↗ | Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid Pills | Terminated | Ajay Wasan, MD, Msc | Phase 4 | 2018-05-01 | This study will examine how the use of Xtampza ER, an opioid analgesic packaged in openable microsphere-containing capsules, affects swallowing satisfaction, pain, and physical and mental health outcomes in chronic pain patients. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for XTAMPZA ER
Condition Name
Clinical Trial Locations for XTAMPZA ER
Trials by Country
Clinical Trial Progress for XTAMPZA ER
Clinical Trial Phase
Clinical Trial Sponsors for XTAMPZA ER
Sponsor Name